| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Efluelda 0.7 ml | suspension injectable en seringue préremplie | suspension injectable en seringue préremplie (Haemagglutininum Influenzae a (H1N1) (Virus Souche A/michigan/45/2015 (H1N1)-Like: Reassortant Virus nymc X-275 Derived from A/michigan/45/2015) 60µg / 0.7ml, Haemagglutininum Influenzae a (H3N2) (Virus Souche A/singapore/infimh-16-0019/2016 (H3N2)-Like: Reassortant Virus Ivr-186 Derived from A/singapore/infimh-16-0019/2016 ) 60µg / 0.7ml, Haemagglutininum Influenzae b (Virus Souche B/colorado/06/2017-Like: Reassortant Virus nymc Bx-69A Derived from B/maryland/15/2016 (Victoria Lineage)) 60µg / 0.7ml) | J07BB02 | |
| 02 | Efluelda 0.7 ml | suspension injectable en seringue préremplie | suspension injectable en seringue préremplie (Haemagglutininum Influenzae a (H1N1) (Virus Souche A/victoria/2570/2019 (H1N1)-Like: Reassortant Virus Ivr-215 Derived from A/victoria/2570/2019) 60µg / 0.7ml, Haemagglutininum Influenzae a (H3N2) (Virus Souche A/darwin/9/2021 (H3N2)-Like: Reassortant Virus San-010 Derived from A/darwin/9/2021) 60µg / 0.7ml, Haemagglutininum Influenzae b (Virus Souche B/austria/1359417/2021-Like: Derived from B/michigan/01/2021 (Victoria Lineage)(wild Type)) 60µg / 0.7ml) | J07BB02 | |
| 03 | Efluelda 0.7 ml | suspension injectable en seringue préremplie | suspension injectable en seringue préremplie (Haemagglutininum Influenzae a (H1N1) (Virus Souche A/victoria/4897/2022 (H1N1)-Like: Reassortant Virus Ivr-238 Derived from A/victoria/4897/2022) 60µg / 0.7ml, Haemagglutininum Influenzae a (H3N2) (Virus Souche A/darwin/9/2021 (H3N2)-Like: Reassortant Virus San-010 Derived from A/darwin/9/2021) 60µg / 0.7ml, Haemagglutininum Influenzae b (Virus Souche B/austria/1359417/2021-Like: Derived from B/michigan/01/2021 (Victoria Lineage)(wild Type)) 60µg / 0.7ml) | J07BB02 | |
